Sharvil Patel

Rediff.com » News » Sharvil Patel

News for Sharvil Patel

News
Business

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila......

Cadila launches Remdesivir in India at Rs 2,800 per vial

Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. ......

India's vaccine makers prepare to take on Omicron

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible. IMAGE: A lady shows......

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture......

Govt developing multi-variant Covid-19 vaccine

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus,......

Zydus PAT rises 38% on strong India, US growth

Ahmedabad-headquartered Zydus Lifesciences posted a 17 per cent year-on-year (Y-o-Y) rise in revenue from operations to Rs 6,123 crore, while the net profit increased by 38 per cent to Rs 1,258.6......

'Medicines are just one part of the solution'

'We are looking at what kind of products, diagnostics or other solutions we can offer to become a well-rounded player in a particular disease area globally.' IMAGE: Text. Photograph: Kind courtesy......

Zydus gets China nod for kidney disease drug

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by......

US drug shortage a shot in the arm for Indian pharmaceutical companies

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Image used......

'It was very hard to build an R&D set-up in India'

'In any organisation, a continuous line of leadership, is required.' 'All R&D will be of focus. All the way from Active Pharmaceutical Ingredients to R&D in formulations, to biologics, NCEs,......

Sharvil Patel

News for Sharvil Patel

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Cadila launches Remdesivir in India at Rs 2,800 per vial

India's vaccine makers prepare to take on Omicron

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Govt developing multi-variant Covid-19 vaccine

Zydus PAT rises 38% on strong India, US growth

'Medicines are just one part of the solution'

Zydus gets China nod for kidney disease drug

US drug shortage a shot in the arm for Indian pharmaceutical companies

'It was very hard to build an R&D set-up in India'

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS